TradingView
RocketTickers
Oct 2, 2018 5:27 PM

CLVS Receives Breakthrough Therapy Designation for Rubraca® Long

NASDAQ:CLVS1D

Description

⋅
CLVS: Clovis Oncology, Inc.
2018-10-02 08:00:00
Clovis Oncology Receives Breakthrough Therapy Designation for Rubraca® (rucaparib) for Treatment of BRCA1/2-Mutated Metastatic Castration Resistant Prostate
Beyond Technical Analysis
More